Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.
Find new ideas and classic advice on strategy, innovation and leadership, for global leaders from the world's best business and management experts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback